Charterhouse Invests in Skin Tech Pharma Group
June 21, 2024
Charterhouse Capital Partners has announced an investment in Skin Tech Pharma Group, a Spain-headquartered medical aesthetics manufacturer founded by Dr Philippe Deprez. The partnership will support Skin Tech’s organic growth (product innovation and market entry) and pursue inorganic expansion through targeted M&A while the founder is re-investing in the business.
- Buyers
- Charterhouse Capital Partners
- Targets
- Skin Tech Pharma Group
- Industry
- Medical Devices
- Location
- Catalonia, Spain
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Prelude Growth Partners Makes $15M Minority Investment in Skin Pharm
May 16, 2023
Healthcare Services
Prelude Growth Partners, a female-founded growth equity firm, has made a $15 million minority investment in Skin Pharm to fund the aesthetic clinic's nationwide clinic expansion and product development. Founder and CEO Maegan Griffin will remain in charge as the capital supports new clinic openings and expansion of the company's skincare product line.
-
Charterhouse Capital Partners Invests in PHASTAR
January 5, 2021
Healthcare Services
Charterhouse Capital Partners has made a growth investment in PHASTAR, a specialist biometrics clinical research organisation (CRO). PHASTAR founder Kevin Kane remains CEO and a significant shareholder; Charterhouse will support the company's geographic expansion and capability growth while Nick Edwards joins as non-executive chair.
-
SK Capital Partners Acquires IPACKCHEM Group SAS
April 6, 2021
Manufacturing
SK Capital Partners, a New York-based private investment firm focused on specialty materials and chemicals, has completed the acquisition of IPACKCHEM Group SAS, a Paris-headquartered manufacturer of sustainability-oriented barrier plastic packaging for the crop protection and specialty chemicals markets. SK Capital said it will partner with IPACKCHEM's management to accelerate organic and acquisitive growth and expand the company's global market position.
-
Charterhouse Capital Partners Acquires Controlling Stake in Novetude Santé
November 12, 2020
Education
Charterhouse Capital Partners has acquired a controlling stake in Novetude Santé, a France-based specialist provider of higher education and continuing professional development for healthcare professionals, from BIM. Charterhouse invested alongside Novetude Santé’s management, which retains a shareholding, and intends to support the company’s growth through internationalisation and buy-and-build add-on activity.
-
KKR Makes Minority Investment in SkinSpirit
October 20, 2022
Healthcare Services
KKR has made a minority growth investment in SkinSpirit, a U.S. medical‑aesthetics and medical‑spa platform, to accelerate national expansion and talent development while founder Lynn Heublein remains in leadership. GreyLion, an earlier investor, will remain a minority owner as KKR invests through its Health Care Strategic Growth Fund II to support scaling the business.
-
SK Capital Partners Acquires Apotex Pharmaceutical Holdings
April 3, 2023
Pharmaceuticals
An affiliate of funds advised by SK Capital Partners has completed the acquisition of Apotex Pharmaceutical Holdings Inc. SK Capital appointed Allan Oberman as President and CEO as it looks to transform Apotex into a Canadian-based global health company; Apotex employs nearly 8,000 people and sells affordable medicines in over 100 countries.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.